Your browser doesn't support javascript.
loading
Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia.
Sonnet, Miriam; Claus, Rainer; Becker, Natalia; Zucknick, Manuela; Petersen, Jana; Lipka, Daniel B; Oakes, Christopher C; Andrulis, Mindaugas; Lier, Amelie; Milsom, Michael D; Witte, Tania; Gu, Lei; Kim-Wanner, Soo-Zin; Schirmacher, Peter; Wulfert, Michael; Gattermann, Norbert; Lübbert, Michael; Rosenbauer, Frank; Rehli, Michael; Bullinger, Lars; Weichenhan, Dieter; Plass, Christoph.
Afiliación
  • Sonnet M; Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
  • Claus R; Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany ; Department of Hematology/Oncology, University Medical Center, D-79106 Freiburg, Germany.
  • Becker N; Division of Biostatistics, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
  • Zucknick M; Division of Biostatistics, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
  • Petersen J; Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
  • Lipka DB; Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
  • Oakes CC; Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
  • Andrulis M; Department of General Pathology, Institute of Pathology, University Heidelberg, D-69120 Heidelberg, Germany.
  • Lier A; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
  • Milsom MD; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
  • Witte T; Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
  • Gu L; Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany ; Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
  • Kim-Wanner SZ; Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
  • Schirmacher P; Department of General Pathology, Institute of Pathology, University Heidelberg, D-69120 Heidelberg, Germany.
  • Wulfert M; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, D-40225 Düsseldorf, Germany.
  • Gattermann N; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, D-40225 Düsseldorf, Germany.
  • Lübbert M; Department of Hematology/Oncology, University Medical Center, D-79106 Freiburg, Germany.
  • Rosenbauer F; Institute of Molecular Tumor Biology, Westfälische Wilhelms Universität, D-48149 Münster, Germany.
  • Rehli M; Department of Hematology and Oncology, University Hospital Regensburg, D-93042 Regensburg, Germany.
  • Bullinger L; Department of Internal Medicine III, University of Ulm, D-89081 Ulm, Germany.
  • Weichenhan D; Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
  • Plass C; Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
Genome Med ; 6(4): 34, 2014.
Article en En | MEDLINE | ID: mdl-24944583
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Genome Med Año: 2014 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Genome Med Año: 2014 Tipo del documento: Article País de afiliación: Alemania